Now Reading
Reports Say Thailand To Produce Anti-Covid-19 Nasal Spray By September 2022

Reports Say Thailand To Produce Anti-Covid-19 Nasal Spray By September 2022

The nasal spray is said to be able to prevent Covid-19.

Adeline Leong

Subscribe to our Telegram channel for the latest stories and updates.


A group comprising Thailand’s pharmaceutical and medical supplies experts is working to produce a nasal spray that can prevent Covid-19.

The Star reported that the nasal spray works by helping the body produce antibodies that can fight the Covid-19 virus.

If the nasal spray works, hopefully, it’ll be one of the medications to be considered and approved by the Health Ministry (KKM) to be used here.

According to New Straits Times, Bangkok Post reported that experts from Chulalongkorn University, Silpakom University, Health Systems Research Institute (HSRI), the Government Pharmaceutical Organisation (GPO) and Siam Bioscience worked together on the project.

The joint venture to develop the spray aims to push Thai innovation and research efforts to meet international standards.

A nasal spray might be less scary as compared to injections. Image: TRP File

Reports indicate that the nasal spray will be available to the public for sale in the third quarter, possibly around September this year.

GPO deputy director, Rangsee Patlee, said the Food and Drug Administration (FDA) had granted a certificate to the group to produce respiratory-care medical supplies which permit the distribution of the nasal spray solution developed by the GPO.

The anti-Covid-19 nasal spray is also certified by the International Organisation for Standardisation (ISO) for medical devices.

As our facility has passed ISO requirements for medical supply distribution, we can guarantee that the production of this anti-Covid-19 product is safe and of good quality.

GPO deputy director, Rangsee Patlee

Thailand has produced its own Covid-19 vaccines too

New Straits Times reported that GPO is also known for producing the second Thailand Covid-19 vaccine, HXP-GPOVac, that had gone through its first and second clinical trials.

Lab results showed that the vaccine can ward off the Omicron variant and is being considered for approval by the FDA. The third trial and distribution of the vaccine could begin by mid-2023.

In addition, the mRNA vaccine developed by the Chula Vaccine Research Centre at Chulalongkorn University and the King Chulalongkorn Memorial Hospital in Bangkok has shown its efficiency that matches the Pfizer and Moderna vaccines, The Star reported.

The vaccine will undergo its this third clinical trial and will be ready for public use once it’s approved by FDA.

Image: TRP File

Malaysia is studying other vaccine methods

In March 2022, The Malay Mail reported that the Malaysian government is studying other methods to administer vaccines, such as oral medicines or nasal sprays.

Science, Technology and Innovation Deputy Minister Datuk Ahmad Amzad Hashim said the different methods of administering vaccines were being studied because they were people who fear needles which may discourage them from taking Covid-19 vaccines.

The Covid-19 pandemic has led unscrupulous people and companies to peddle questionable cures.

Most of these supposed Covid-19 cures take advantage of people’s desperation and rely on the placebo effect.

To be safe, it’s best to consult with your physician before downing any miracle medicines.

READ MORE: Mobile Phone Retailer Slapped With RM10,000 Fine For Selling Unregistered Covid-19 Medicine In Sabah

READ MORE: Aunty Hospitalised After Taking Ivermectin, Convinced mRNA Vaccines Are Against Her Religion

READ MORE: Malaysia’s Clinical Study On Ineffectiveness Of Ivermectin Is Published In Medical Journal


Share your thoughts with us via TRP’s FacebookTwitter, and Instagram.

View Comments (0)

Leave a Reply

Your email address will not be published.

3 + 20 =

© 2021 The Rakyat Post. All Rights Reserved. Owned by 3rd Wave Media Sdn Bhd